Results of Entecavir treatment in patients with chronic hepatitis B
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2013, Vol 3, Issue 4
Abstract
Objective: This study was designed to determine the efficacy and safety of Entecavir (ETV) after 96 weeks treatment in patients with chronic viral hepatitis B (CHB). Methods: Thirty-eight patients were included into the study. The criteria for starting ETV treatment were as follows: elevated ALT levels >upper limit of normal (ULN) two times, with HBV-DNA levels ≥5 log10 copies/ml (≥20000 IU/mL), in HBe Ag positive patients, ≥4log10 copies/ml (≥2000IU/mL) in HBe Ag negative patients and liver damage was confirmed by histopathology (Knodell HAI ≥4 or fibrosis ≥1). Patients were followed up every 12 weeks by virological and biochemical tests. Results: Twenty-four of 38 patients (63.2%) were male. Mean age of patients were 38.6 years, 14 of them were HBeAg positive (36.8%). At baseline, median ALT level was detected as 106.7 IU/ml, median HBV DNA levels were 4.8 x 107 copy/ml, and mean Knodell HAI score was nine. Eleven of 14 HBe Ag positive patients (78.6%) were treatment-naïve. No resistance mutation was determined during treatment. Biochemical responses (BR) at 48th and 96th week were 100% and virologic response (VR) were 57.1%, and 50%, respectively. Serological response (SR) at 48th and 96th weeks were 35.7% and 42.8% respectively. Fifteen (62.5%) of 24 HBe Ag negative patients were treatment-naïve; two patients were detected to have lamivudine resistance mutation. At 48th and 96th week, BR was 95.8%, and 100%, respectively; and VR were 83.3% both. Conclusion: In our study, virologic response was significantly high after two years of therapy with Entecavir in HBe Ag negative patients. J Microbiol Infect Dis 2013;3(4): 176-180 Key words: Chronic hepatitis B, Entecavir, therapy
Authors and Affiliations
Şükran Köse, Melda Türken, Bengü Tatar
Keywords
Related Articles
- EP ID EP162283
- DOI 10.5799/ahinjs.02.2013.04.0104
- Views 127
- Downloads 0
Lemierre sendromu ve sağ adneks absesi: Bir olgu sunumu ve literatür incelemesi
Lemierre sendromu çok nadir görülen ve tamamen tedavi edilebilen bir durumdur. Erken tanı ve uygun tedavi için çok erkenden şüphelenmek gerekmektedir. Burada boğaz ağrısı, ateş, boyun ağrısı, karın ağrısını takip eden bu...
Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases
Objective: The combination of pegylated interferon-α (PEG-IFN) and ribavirin has become a mainstay in the treatment of chronic hepatitis C (CHC). We aimed to evaluate the efficacy of this treatment in patients with CHC,...
Nörovirus kaynaklı bir gastroenterit salgını
Amaç: Bu çalışmada içme suyu kaynaklı bir norovirüs salgınının epidemiyolojik özelliklerini ve salgın kontrol çalışmalarını sunmayı amaçladık. Yöntemler:Bu çalışmada Nisan 2010’da Isparta Keçiborlu ilçesinde yaşanan sal...
Surviving Mardi Gras in an Intensive Care Unit
Penicilliosis is a life threatening fungal infection caused by Penicillium marneffei (PM). It has a high mortality rate if not picked up in time and treated appropriately. Making an early diagnosis is a key in improving...
Patterns of Antimicrobial Resistance in a Pediatric Cardiac Intensive Care Unit: Five Years’ Experience
Objectives: The identification of antimicrobial resistance of isolates present in pediatric cardiac intensive care unit (PCICU) is important to prevent further spread, because this department limited choice of antibiotic...